A very innovative observation of the study was that in patients presenting AFP serum levels > 1000 ng/mL, 3 points are attributed, irrespective of the number or size of nodules; thus, they may be immediately considered at high risk of HCC recurrence. The gene discussed is AFP; the disease is hepatocellular carcinoma.